Antacid and Oxetacaine oral suspension
BNF presentation 0101010N0AAABAB within chapter Gastro-Intestinal System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0101010N0AAABAB
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
860
NHS spend (£)
£31,947.79
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 103 |
| February 2025 | 1 |
| December 2024 | 29 |
| November 2024 | 133 |
| October 2024 | 120 |
| August 2024 | 5 |
| July 2024 | 121 |
| May 2024 | 17 |
| July 2021 | 53 |
| June 2021 | 38 |
| December 2020 | 97 |
| November 2020 | 143 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 16 | No data available |
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |